Run Sheng Jiang
President at WALVAX BIOTECHNOLOGY CO., LTD.
Net worth: 4 M $ as of 2024-03-30
Profile
Run Sheng Jiang occupies the position of President & Director at Walvax Biotechnology Co., Ltd. and Chairman for Shanghai Zerun Biotech Co., Ltd. (a subsidiary of Walvax Biotechnology Co., Ltd.).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-06-29 | 930,000 ( 0.06% ) | 2 M $ | 2024-03-30 | |
| 2023-09-29 | 773,437 ( 1.64% ) | 2 M $ | 2024-03-30 |
Run Sheng Jiang active positions
| Companies | Position | Start |
|---|---|---|
| WALVAX BIOTECHNOLOGY CO., LTD. | President | 2016-06-21 |
Shanghai Zerun Biotechnology Co., Ltd.
 Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China. | Chairman | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| WALVAX BIOTECHNOLOGY CO., LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Shanghai Zerun Biotechnology Co., Ltd.
Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China. | Health Technology |
- Stock Market
- Insiders
- Run Sheng Jiang
